A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED PHASE 4 CLINICAL TRIAL TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF AVACOPAN IN PARTICIPANTS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) ASSOCIATED VASCULITIS
- Registry ID
- 20220159
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE4
- Study type
- INTERVENTIONAL
- Sponsor
- AMGEN CANADA INC
- Last update
- 2025-11-25
Conditions
- VASCULAR INFLAMMATION
- ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODY (ANCA)-ASSOCIATED VASCULITIS
Related clinical trials
- PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP,
MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TARPERPRUMIG IN ADULT
PARTICIPANTS WITH ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
- A PHASE 3, OPEN-LABEL, UNCONTROLLED SINGLE-ARM STUDY TO EVALUATE THE EFFICACY,
PHARMACOKINETICS, AND SAFETY OF AVACOPAN IN COMBINATION WITH A RITUXIMAB OR A
CYCLOPHOSPHAMIDE-CONTAINING REGIMEN IN CHILDREN FROM 6 YEARS TO < 18 YEARS OF AGE WITH ACTIVE
ANCA-ASSOCIATED VASCULITIS (AAV)
- CANAGLIFLOZIN TARGETING VASCULAR INFLAMMATION: AN OTTAWA IMAGING STUDY (CANTOR SING) - A PILOT STUDY
- LOW DOSE NALTREXONE TO IMPROVE PHYSICAL HEALTH IN PATIENTS WITH VASCULITIS (LODONAVASC)
- A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECTS OF COLCHICINE ON VASCULAR INFLAMMATION AS ASSESSED WITH POSITRON EMISSION TOMOGRAPHY (PET) IMAGING IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE
View on source registry